pharmaceutical · input
Includes HPAI vaccines (under emergency use study in US), biosecurity disinfectants, PPE, and depopulation services. The 2022–2025 HPAI outbreak destroyed 168+ million birds and cost the US government $1.4 billion+ in compensation. USDA committed $1 billion in 2025 for vaccine R&D.
5
Source countries
5
Companies
1
Goods affected
0
Claims on record
What depends on it
1 essential American goods rely on poultry biosecurity inputs & hpai vaccines somewhere upstream in their supply chain.
Where it comes from
Share of global supply, by country.
| Country | Share of supply |
|---|---|
| USUnited States | 35% |
| DEGermany | 22% |
| FRFrance | 15% |
| CNChina | 12% |
| NLNetherlands | 8% |
Who makes it
5 companies produce poultry biosecurity inputs & hpai vaccines.
Zoetis Inc. (NYSE: ZTS; ~$8.5B revenue; Parsippany NJ) is the world's largest animal health company, spun off from Pfizer in 2013. Zoetis manufactures TROVAC-NDV and conventional inactivated AI vaccines for commercial poultry, along with broad-spectrum animal health products for livestock and companion animals across 100 countries.
Boehringer Ingelheim Animal Health (Ingelheim am Rhein, Germany; private; ~€4B animal health revenue) manufactures VECTORMUNE HVT-AI recombinant poultry vaccines using herpesvirus of turkeys (HVT) as a vector. The recombinant platform simultaneously protects against Marek's disease and avian influenza. US manufacturing at Pope Valley CA and Duluth GA. Boehringer Ingelheim is the second-largest animal health company globally.
Ceva Santé Animale (Libourne, France; private; ~€1.7B revenue) is the 5th largest animal health company globally and a major poultry vaccine manufacturer. Ceva produces MAFIVAC AI vaccines, VECTORMUNE ND+AI recombinant vaccines, and other poultry biologicals. Ceva has significant manufacturing in France (Libourne + Pau), Spain, and the US. In 2022-2024, Ceva supplied emergency AI vaccines to France's commercial duck industry during HPAI H5N1 outbreaks.
Merck Animal Health (Madison NJ; division of Merck & Co.; ~$5.5B revenue) manufactures AviPro brand avian influenza and Newcastle disease vaccines for commercial poultry. Products sold as MSD Animal Health outside North America. Merck Animal Health is the third-largest animal health company globally. De Soto KS biologics manufacturing site.
Phibro Animal Health Corporation (Teaneck NJ; NASDAQ: PAHC; ~$1B revenue) manufactures POULVAC brand poultry vaccines (acquired from Fort Dodge/Zoetis divestiture) along with medicated feed additives and nutritional products. Phibro serves commercial poultry producers globally with AI vaccines, Newcastle disease biologics, and coccidiostats.
